The re-emergence of antigen-specific tolerance as a potential therapy for MS

Targets of the humoral autoimmune response in multiple sclerosis

(2014) Judith Fraussen et al.   AUTOIMMUNITY REVIEWS

Conflicting consequences of immunity to cancer versus autoimmunity to neurons: Insights from paraneoplastic disease

(2014) Lawrence Steinman   EUROPEAN JOURNAL OF IMMUNOLOGY

From defining antigens to new therapies in multiple sclerosis: Honoring the contributions of Ruth Arnon and Michael Sela

(2014) Lawrence Steinman et al.   JOURNAL OF AUTOIMMUNITY

The Charcot Lecture | Beating MS: A story of B cells, with twists and turns

(2014) Stephen L Hauser   Multiple Sclerosis Journal

Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy

(2014) Rhoanne C McPherson et al.   eLife

A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?

(2013) Kerrie Vaughan et al.   JOURNAL OF NEUROIMMUNOLOGY

Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients

(2013) Rebecca C Selter et al.   Multiple Sclerosis Journal

Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes

(2013) B. O. Roep et al.   Science Translational Medicine

Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

(2013) A. Lutterotti et al.   Science Translational Medicine

Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment

(2013) Agata Walczak et al.   JAMA Neurology

Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica

(2012) Lawrence Steinman et al.   ANNALS OF NEUROLOGY

The discovery of natalizumab, a potent therapeutic for multiple sclerosis

(2012) Lawrence Steinman   JOURNAL OF CELL BIOLOGY

Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis

(2012) Francisco J. Quintana et al.   JOURNAL OF NEUROIMMUNOLOGY

Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation

(2012) P. P. Ho et al.   Science Translational Medicine

Anti-Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica

(2011) Lukmanee Tradtrantip et al.   ANNALS OF NEUROLOGY

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

(2011) M. S. Freedman et al.   NEUROLOGY

Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosis

(2010) Lawrence Steinman et al.   ANNALS OF NEUROLOGY

Immune regulation of multiple sclerosis by transdermally applied myelin peptides

(2010) Maciej Juryńczyk et al.   ANNALS OF NEUROLOGY

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis

(2008) Hideki Garren et al.   ANNALS OF NEUROLOGY

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets

(2008) May H. Han et al.   NATURE